Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay

International Journal of Infectious Diseases - Tập 113 - Trang 359-366 - 2021
Si-Ho Kim1, Suhyun Oh2, Eliel Nham3, Jae-Hoon Ko3, Kyungmin Huh3, Sun Young Cho3, Cheol-In Kang3, Doo Ryeon Chung3, Gyu-Seong Choi4, Jong Man Kim4, Jae-Won Joh4, Kyong Ran Peck3
1Division of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University, Changwon, Korea
2Department of Internal Medicine, Seogwipo Medical Center, Jeju, Korea
3Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
4Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Tài liệu tham khảo

Abad, 2019, Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review, Transpl Infect Dis, 21, e13178, 10.1111/tid.13178 Agoglia, 2011, Tuberculosis in liver transplant recipients: prophylaxis in an endemic area, Transplant Proc, 43, 199, 10.1016/j.transproceed.2010.12.033 Chen, 2015, Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort Study, Am J Transplant, 15, 2180, 10.1111/ajt.13235 Cho, 2018, Tuberculosis control in the Republic of Korea, Epidemiol Health, 40, 10.4178/epih.e2018036 Dheda, 2016, Tuberculosis. Lancet, 387, 1211, 10.1016/S0140-6736(15)00151-8 Fabrega, 2012, Chemoprophylaxis with isoniazid in liver transplant recipients, Liver Transpl, 18, 1110, 10.1002/lt.23480 Ha, 2012, Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients, Transpl Infect Dis, 14, 626, 10.1111/j.1399-3062.2012.00721.x Haddad, 2018, Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015, Emerg Infect Dis, 24, 1930, 10.3201/eid2410.180716 Hand, 2018, Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON((R)) -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant, Transpl Infect Dis, 20, e12845, 10.1111/tid.12845 Holty, 2009, Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data, Liver Transpl, 15, 894, 10.1002/lt.21709 Horne, 2013, Challenging Issues in Tuberculosis in Solid Organ Transplantation, Clinical Infectious Diseases, 57, 1473, 10.1093/cid/cit488 Jeong, 2012, Positive Tuberculin Skin Test or Interferon-Gamma Release Assay in Patients with Radiographic Lesion Suggesting Old Healed Tuberculosis, J Korean Med Sci, 27, 761, 10.3346/jkms.2012.27.7.761 Kamath, 2007, The model for end-stage liver disease (MELD), Hepatology, 45, 797, 10.1002/hep.21563 Kim, 2009, Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population, BMC Infect Dis, 9, 207, 10.1186/1471-2334-9-207 Lin, 2010, Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model, Arthritis Rheum, 62, 340, 10.1002/art.27271 Lyu, 2011, Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates, Liver Transpl, 17, 963, 10.1002/lt.22319 Mamishi, 2020, Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysis, Microb Pathog, 139, 10.1016/j.micpath.2019.103894 Maung Myint, 2019, Tests for latent tuberculosis in candidates for solid organ transplantation: A systematic review and meta-analysis, Clin Transplant, 33, e13643, 10.1111/ctr.13643 Metcalfe, 2013, Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice, Am J Respir Crit Care Med, 187, 206, 10.1164/rccm.201203-0430OC Moon, 2017, Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area, Ann Transplant, 22, 338, 10.12659/AOT.902989 Rangaka, 2012, Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis, Lancet Infect Dis, 12, 45, 10.1016/S1473-3099(11)70210-9 Reis-Santos, 2013, Tuberculosis prevalence in renal transplant recipients: systematic review and meta-analysis, J Bras Nefrol, 35, 206, 10.5935/0101-2800.20130033 Rim, 2018, Notified Tuberculosis in the Republic of Korea, 2018, PUBLIC HEALTH WEEKLY REPORT, 12, 6 Sipeki, 2014, Immune dysfunction in cirrhosis, World J Gastroenterol, 20, 2564, 10.3748/wjg.v20.i10.2564 Subramanian, 2009, Mycobacterium tuberculosis in solid organ transplant recipients, Am J Transplant, 9, S57, 10.1111/j.1600-6143.2009.02894.x Torre-Cisneros, 2015, Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial, Clin Infect Dis, 60, 1642, 10.1093/cid/civ156 Yang, 2020, A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia, Transpl Infect Dis, e13482